Similarly, elevated LOXL1 in SKCM, LUAD and BLCA and elevated LOXL2 in BLCA were associated with reduced ORRs and poorer survival (Figure 6B,C,E,F). Here, LOXL2 is linked to bladder transitional cell carcinoma.